Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Enzyme-linked immunosorbent assay (ELISA), also known as an enzyme immunoassay (EIA), is a biochemical technique used mainly in immunology to detect the presence of an antibody or an antigen in a sample. The ELISA has been used as a diagnostic tool in medicine and plant pathology, as well as a quality-control check in various industries,such as ELISA application in food industry.
Scope of the Report:
This report focuses on the Enzyme-Linked Immunosorbent Assay (ELISA) in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
R&D Systems
Thermo Fisher Scientific
Ortho Clinical Diagnostics
BD Biosciences
ZEUS Scientific
Bio-Rad Laboratories
ALPCO
Enzo Life Sciences
BioMérieux
EMD Millipore
BioLegend
LOEWE Biochemica
Mercodia
Cusabio
Shanghai Kehua Bio-engineering
Market Segment by Regions, regional analysis covers
Europe (Germany, France, UK, Russia, Italy and Turkey)
Middle East (Saudi Arabia, Israel, UAE and Iran)
Africa (South Africa, Nigeria, Egypt and Algeria)
Market Segment by Type, covers
Sandwich ELISA
Indirect ELISA
Competitive ELISA
Others
Market Segment by Applications, can be divided into
Immunology
Inflammation
Infectious Diseases
Cancer
Protein Quantitation
Others
There are 13 Chapters to deeply display the EMEA Enzyme-Linked Immunosorbent Assay (ELISA) market.
Chapter 1, to describe Enzyme-Linked Immunosorbent Assay (ELISA) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Enzyme-Linked Immunosorbent Assay (ELISA), with sales, revenue, and price of Enzyme-Linked Immunosorbent Assay (ELISA), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of Enzyme-Linked Immunosorbent Assay (ELISA), for each region, from 2012 to 2017;
Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;
Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;
Chapter 10, Enzyme-Linked Immunosorbent Assay (ELISA) market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;
Chapter 11, 12 and 13, to describe Enzyme-Linked Immunosorbent Assay (ELISA) research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source
Scope of the Report:
This report focuses on the Enzyme-Linked Immunosorbent Assay (ELISA) in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
R&D Systems
Thermo Fisher Scientific
Ortho Clinical Diagnostics
BD Biosciences
ZEUS Scientific
Bio-Rad Laboratories
ALPCO
Enzo Life Sciences
BioMérieux
EMD Millipore
BioLegend
LOEWE Biochemica
Mercodia
Cusabio
Shanghai Kehua Bio-engineering
Market Segment by Regions, regional analysis covers
Europe (Germany, France, UK, Russia, Italy and Turkey)
Middle East (Saudi Arabia, Israel, UAE and Iran)
Africa (South Africa, Nigeria, Egypt and Algeria)
Market Segment by Type, covers
Sandwich ELISA
Indirect ELISA
Competitive ELISA
Others
Market Segment by Applications, can be divided into
Immunology
Inflammation
Infectious Diseases
Cancer
Protein Quantitation
Others
There are 13 Chapters to deeply display the EMEA Enzyme-Linked Immunosorbent Assay (ELISA) market.
Chapter 1, to describe Enzyme-Linked Immunosorbent Assay (ELISA) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Enzyme-Linked Immunosorbent Assay (ELISA), with sales, revenue, and price of Enzyme-Linked Immunosorbent Assay (ELISA), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of Enzyme-Linked Immunosorbent Assay (ELISA), for each region, from 2012 to 2017;
Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;
Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;
Chapter 10, Enzyme-Linked Immunosorbent Assay (ELISA) market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;
Chapter 11, 12 and 13, to describe Enzyme-Linked Immunosorbent Assay (ELISA) research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
